Assessing Fall Risk Using Transcranial Magnetic Stimulation and Quantitative Sensory Testing
Launched by CHULALONGKORN UNIVERSITY · Jun 24, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how certain tests can help understand the risk of falls in older adults. As we age, our bodies can change in ways that make it harder to maintain balance, which increases the chances of falling. The study focuses on people aged 65 to 80 years old and aims to find out how using techniques like transcranial magnetic stimulation (a non-invasive method that stimulates nerve cells) and quantitative sensory testing (which measures how well you can feel different sensations) can help assess fall risk.
To be eligible for this trial, participants need to be between 65 and 80 years old and in good health, meaning they shouldn't have had certain surgeries on their legs, or conditions like strokes or Parkinson's disease. Participants can expect to undergo a series of tests that will help researchers learn more about how their sensory and motor skills affect their balance. Overall, this study is important because it aims to find better ways to keep older adults safe from falls, which can lead to serious health issues and loss of independence.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1) Male and female individuals aged 65-80 years.
- Exclusion Criteria:
- • 1. History of previous lower limb surgery, such as total knee replacement or ankle surgery.
- • 2. History of a neurological disorder, such as stroke or Parkinson's disease.
- • 3. History of vestibular disease, such as Meniere's disease.
- • 4. History of seizures or epilepsy.
- • 5. The presence of metal implanted devices in or around the head area
- • 6. MoCA score \< 26
About Chulalongkorn University
Chulalongkorn University, one of Thailand's premier academic institutions, is dedicated to advancing medical research and enhancing healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise in various medical fields to conduct rigorous scientific investigations. Chulalongkorn University aims to contribute to global health advancements by fostering a culture of excellence in research, education, and community service, ultimately improving patient care and public health standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bangkok, , Thailand
Patients applied
Trial Officials
Jakkrit Amornvit, MD
Principal Investigator
Chulalongkorn University
Phunsuk Kantha, PT.,PhD
Principal Investigator
Mahidol University
Kulvara Lapanan, PT
Principal Investigator
Chulalongkorn University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported